• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中微小RNA表达谱分析显示微小RNA-224上调且凋亡抑制因子-5为微小RNA-224特异性靶点。

Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.

作者信息

Wang Yu, Lee Alvin T C, Ma Joel Z I, Wang Jingbo, Ren Jianwei, Yang Yuchen, Tantoso Erwin, Li Kuo-Bin, Ooi London L P J, Tan Patrick, Lee Caroline G L

机构信息

Department of Biochemistry, National University of Singapore, Singapore 119077, Singapore.

出版信息

J Biol Chem. 2008 May 9;283(19):13205-15. doi: 10.1074/jbc.M707629200. Epub 2008 Mar 4.

DOI:10.1074/jbc.M707629200
PMID:18319255
Abstract

Like other cancers, aberrant gene regulation features significantly in hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) were recently found to regulate gene expression at the post-transcriptional/translational levels. The expression profiles of 157 miRNAs were examined in 19 HCC patients, and 19 up-regulated and 3 down-regulated miRNAs were found to be associated with HCC. Putative gene targets of these 22 miRNAs were predicted in silico and were significantly enriched in 34 biological pathways, most of which are frequently dysregulated during carcinogenesis. Further characterization of microRNA-224 (miR-224), the most significantly up-regulated miRNA in HCC patients, revealed that miR-224 increases apoptotic cell death as well as proliferation and targets apoptosis inhibitor-5 (API-5) to inhibit API-5 transcript expression. Significantly, miR-224 expression was found to be inversely correlated with API-5 expression in HCC patients (p < 0.05). Hence, our findings define a true in vivo target of miR-224 and reaffirm the important role of miRNAs in the dysregulation of cellular processes that may ultimately lead to tumorigenesis.

摘要

与其他癌症一样,异常的基因调控在肝细胞癌(HCC)中具有显著特征。最近发现,微小RNA(miRNA)在转录后/翻译水平调控基因表达。对19例HCC患者的157种miRNA的表达谱进行了检测,发现19种上调和3种下调的miRNA与HCC相关。通过计算机模拟预测了这22种miRNA的潜在基因靶点,这些靶点在34条生物学途径中显著富集,其中大多数在致癌过程中经常失调。对HCC患者中上调最显著的miRNA-224(miR-224)进行进一步研究发现,miR-224可增加凋亡细胞死亡以及细胞增殖,并靶向凋亡抑制因子-5(API-5)抑制API-5转录本表达。值得注意的是,在HCC患者中发现miR-224表达与API-5表达呈负相关(p < 0.05)。因此,我们的研究结果确定了miR-224在体内的真正靶点,并重申了miRNA在细胞过程失调中可能最终导致肿瘤发生的重要作用。

相似文献

1
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.肝细胞癌中微小RNA表达谱分析显示微小RNA-224上调且凋亡抑制因子-5为微小RNA-224特异性靶点。
J Biol Chem. 2008 May 9;283(19):13205-15. doi: 10.1074/jbc.M707629200. Epub 2008 Mar 4.
2
Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.对微小RNA调控的蛋白质相互作用网络的综合分析揭示了微小RNA - 149通过靶向AKT - mTOR途径在人类肝细胞癌中的肿瘤抑制作用。
Mol Cancer. 2014 Nov 26;13:253. doi: 10.1186/1476-4598-13-253.
3
MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.微小RNA-133b通过靶向沉默调节蛋白1抑制肝癌细胞进展。
Exp Cell Res. 2016 May 1;343(2):135-147. doi: 10.1016/j.yexcr.2016.03.027. Epub 2016 Apr 19.
4
The long noncoding RNA links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma.长链非编码RNA将微小RNA miR-215与肝细胞癌中癌基因CRKL介导的信号传导联系起来。
J Biol Chem. 2017 Oct 27;292(43):17939-17949. doi: 10.1074/jbc.M116.773978. Epub 2017 Sep 8.
5
MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.微小 RNA-375 在肝癌中靶向 AEG-1 并抑制肝癌细胞的体内外生长。
Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500. Epub 2011 Nov 7.
6
Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证鉴定肝癌中与侵袭转移相关的 microRNAs。
J Transl Med. 2018 Sep 29;16(1):266. doi: 10.1186/s12967-018-1639-8.
7
MicroRNA-1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor-5 (API-5).微小RNA-1通过靶向凋亡抑制因子5(API-5)促进肝癌细胞凋亡。
FEBS Lett. 2015 Jan 2;589(1):68-76. doi: 10.1016/j.febslet.2014.11.025. Epub 2014 Nov 27.
8
Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.microRNA-224 参与肝癌细胞的增殖、迁移、侵袭和抗凋亡。
J Gastroenterol Hepatol. 2013 Mar;28(3):565-75. doi: 10.1111/j.1440-1746.2012.07271.x.
9
miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP.miR-23c 通过抑制 ERBB2IP 来抑制人肝癌细胞的肿瘤生长。
Biomed Pharmacother. 2018 Nov;107:424-432. doi: 10.1016/j.biopha.2018.07.155. Epub 2018 Aug 10.
10
Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.鉴定参与 HBV 相关 HCC 发病机制的潜在 miRNA-mRNA 调控网络。
J Transl Med. 2019 Jan 3;17(1):7. doi: 10.1186/s12967-018-1761-7.

引用本文的文献

1
Genetic Alchemy unveiled: MicroRNA-mediated gene therapy as the Artisan craft in the battlefront against hepatocellular carcinoma-a comprehensive chronicle of strategies and innovations.揭开基因炼金术的面纱:微小RNA介导的基因治疗在对抗肝细胞癌前线的精湛技艺——策略与创新的全面记录
Front Genet. 2024 Jun 10;15:1356972. doi: 10.3389/fgene.2024.1356972. eCollection 2024.
2
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.探讨肝细胞癌中非编码 RNA 机制:对治疗和预后的影响。
Front Immunol. 2024 May 10;15:1400744. doi: 10.3389/fimmu.2024.1400744. eCollection 2024.
3
Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate.
凋亡抑制因子5:细胞命运的多面调节因子
Biomolecules. 2024 Jan 22;14(1):136. doi: 10.3390/biom14010136.
4
Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma.循环非编码RNA在肝细胞癌诊断与治疗中的研究进展
Front Oncol. 2023 Jul 20;13:1204715. doi: 10.3389/fonc.2023.1204715. eCollection 2023.
5
In Silico Analysis of MicroRNA Expression Data in Liver Cancer.肝癌中微小RNA表达数据的计算机分析
Cancer Inform. 2023 May 10;22:11769351231171743. doi: 10.1177/11769351231171743. eCollection 2023.
6
Bioinformatics and systems biology approaches to identify molecular targeting mechanism influenced by COVID-19 on heart failure.生物信息学和系统生物学方法鉴定 COVID-19 对心力衰竭影响的分子靶向机制。
Front Immunol. 2022 Nov 7;13:1052850. doi: 10.3389/fimmu.2022.1052850. eCollection 2022.
7
Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model.验证 AAC-11 衍生肽在单个移植物 Sézary 患者来源异种移植小鼠模型中的抗肿瘤活性。
Cells. 2022 Sep 20;11(19):2933. doi: 10.3390/cells11192933.
8
HCV and tumor-initiating stem-like cells.丙型肝炎病毒与肿瘤起始干细胞样细胞
Front Physiol. 2022 Sep 15;13:903302. doi: 10.3389/fphys.2022.903302. eCollection 2022.
9
Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians.评估循环中微小RNA-326、微小RNA-424和微小RNA-511水平作为埃及人肝细胞癌生物标志物的研究
World J Hepatol. 2022 Aug 27;14(8):1562-1575. doi: 10.4254/wjh.v14.i8.1562.
10
miRNA in Molecular Diagnostics.分子诊断中的微小RNA
Bioengineering (Basel). 2022 Sep 9;9(9):459. doi: 10.3390/bioengineering9090459.